February 2017

Vancouver, British Columbia–(Newsfile Corp. – February 23, 2017) – Today we are featuring Alliance Growers (CSE: ACG), a diversified cannabis company, driven by what the company terms as its “Four Pillars” organization plan. These Four Pillars refer to its planned Cannabis Botany Centre, strategic investments in Licensed Producer applicants, cannabidiol supply and distribution, and research and development.

InvestmentPitch Media has produced a “video news alert” which provides a brief overview of Alliance Growers. If this link is not enabled, please visit www.InvestmentPitch.com and enter “Alliance” in the search box. It is also available for viewing on YouTube (click here).

Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_4mbmtj52/Alliance-Growers-CSEACG-Featured-Company

To finance its many initiatives, the company recently announced that it was negotiating terms on an equity facility of $5 to $10 million, in addition to its previously announced plans to raise up to $3 million through the sale of up to 15 million units at a price of $0.20 per unit.

Dennis Petke, President and CEO stated: “We are very excited to be able to take advantage of the equity facility to be able to execute on our business plan. The equity firm we are negotiating with has financed other well-known Canadian cannabis companies in the past 2 years. Over time we expect new investors and our shareholders to begin to see that we are building a truly global cannabis company, and this is what makes Alliance Growers stand out from other Canadian cannabis companies whose entire business is directly affected by Health Canada rules and regulations.”

Alliance recently executed an agreement with Botanical Research in Motion International for an Exclusive Canada License to jointly develop a Cannabis Botany Centre, and has identified a 40-acre property, to the east of Vancouver, that is zoned for Health Canada Licensed Producer facilities. They initially plan to build a 40,000-square foot Cannabis Botany Centre, and potentially develop up to 1 million square feet of facility space. The proposed centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Through a series of strategic alliances and investments in potential Licensed Producers at various stages in the license process, the company is focused on securing long term plantlet supply contracts for the centre and off-take agreements at wholesale cost for flower to be used for cannabidiol oil extraction.

One such investment is the first $25,000 of a $375,000 investment into New Maple Holdings, the parent of Canwe Growers. Canwe (www.canwe.ca) is working on an application for a Producer’s License under the Access to Cannabis for Medical Purposes Regulations. Canwe has amassed a stellar team, including licensed producer MedReleaf’s former head grower and his number two aide, both expert cannabis growers with extensive seed to sale experience.

The company is negotiating terms for an equity investment and/or joint venture with an Israeli medical cannabis company, which has permitted land in an offshore, low operating cost jurisdiction, to grow cannabis plants. The Israeli company brings first-class Israeli technology for production and processing, which according to Alliance management, would facilitate the importation of CBD oil into the USA, into Canada when legalized, and into Germany, under its new laws.

Alliance is co-developing a cannabis marketplace App with a private B.C. company. When completed, the Canna App will allow users to locate local dispensaries, browse and search product catalogues, purchase and arrange delivery of products and comment on and rate products and businesses.

The shares are currently trading at $0.165. For more information on the company’s many initiatives, please visit the company’s website, www.alliancegrowers.com, contact Dennis Petke, President & CEO, at 778-331-4266 or email DennisPetke@AllianceGrowers.com.

Investor relations is handled by Rob Grace, Corporate Communications Consultant, who can be reached at 778-998-5431 or by email at RobGrace@AllianceGrowers.com.

About InvestmentPitch Media

Investmentpitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
Read more at http://www.stockhouse.com/news/press-releases/2017/02/23/alliance-growers-a-diversified-cannabis-company-selected-as-featured-company-in#LiJAo3rPmiuRwpOF.99


February 21, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) announces the closing of the first tranche of instalment of its subscription for common shares in New Maple Holdings. Ltd. (“New Maple”), the parent company of Canwe Growers Inc. (“Canwe”).

Canwe (www.canwe.ca) is an Ontario-based company preparing to apply for a producer’s license under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”). Canwe has access to a 22 acre property 1.5 hours north-west of Toronto, where it plans to build a facility focused on producing clean, premium quality cannabis. Canwe has amassed a stellar team which includes licensed producer MedReleaf Corp.’s former Head Grower and his number two aide, both of whom are expert cannabis growers who intimately know the cannabis cultivation cycle from seed to sale. With Alliance Growers’ four-pillar strategy and Canwe’s experienced team, the two companies plan to work together to form business synergies with the goal of creating a strong presence in Canada’s fast-growing medical cannabis space.

Alliance Growers has subscribed for a total of 375,000 common shares of New Maple at a cost of $1.00 per share, which would represent approximately 5% of the outstanding shares of New Maple if the subscription was filled in its entirety today. Alliance Growers acquired an initial common share of New Maple upon incorporation and has acquired an additional 25,000 common shares for $25,000. Alliance Growers is expected to fulfil its commitment to acquire the remaining 350,000 shares by April 30, 2017 for an additional $350,000, failing which New Maple can repurchase all of its shares from Alliance Growers at the original issuance price. The funds are expected to be used by Canwe to prepare its application for a producer’s license in accordance with the ACMPR.

In conjunction with the investment, New Maple and Alliance Growers have entered into a non-binding letter of intent for the negotiation of a business arrangement for the purchase and sale between the parties of live cannabis plants, tissue culture plantlets and other cannabis products and services subject to applicable law and the availability of products between the parties. Alliance Growers will not be able to acquire any such products from Canwe unless Canwe obtains its producer’s license from Health Canada and agrees to enter into a business arrangement with Alliance Growers.

Commenting on the investment in New Maple/Canwe, Dennis Petke, Alliance Growers’ President and CEO said, “I am pleased that we have initiated an investment with such an experienced group applying to become a licensed producer applicant in Ontario.  This relationship is expected to provide synergies and mutual opportunities for going forward for developing business arrangements concerning the purchase and sale between the parties of live cannabis plants and other cannabis products”.

About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 

 

 

 


February 16, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to announce the Company is working with a private B.C. company to co-develop a cannabis marketplace app (“Canna App”).

The Canna App marketplace has been under development for several months and is designed to capitalize on the current and coming medical and recreational marijuana revolution. It is intended to mesh seamlessly with the products and services offered by Alliance Cannabis Botany Centre.  It will provide a means for Licensed Growers and dispensaries to advertise products, facilitating sales and deliveries between Licensed Growers, dispensaries and customers, and aggregating social interactions. The marketplace will be also be user-content driven, allowing it to expand rapidly to meet market demands. The marketplace will be a full-service solution to sourcing, variety, selection, sales and delivery.

The Canna App will be a valuable tool for anybody involved in the cannabis industry, from growers to end users and all points in between. This would include providers of equipment for growing and extraction, plant nutrients, product packaging and other service providers in the industry.

The Canna App will position itself to be the eBay and Amazon of medical and recreational marijuana sales. Due to its user-driven model, the business will be able to expand into the national and international markets, wherever legally available.  The Canna App will also provide unique access to potential customers looking for services that are provided by the Cannabis Botany Centre.

Dennis Petke, Alliance Growers’ President and CEO, comments “We are thrilled to have been given the opportunity to participate in this ground-breaking project. The Canna App will be revolutionary to the cannabis space as it will allow users to be able to locate local dispensaries, browse and search product catalogs, purchase and arrange delivery of products, comment on and rate products and businesses. It will also allow vendors to be able to list their dispensaries allowing users to locate it on a map, create and manage a business page with their own images and details, add or edit their list of products (marijuana strains, edible products, accessories), upload pictures of their business and products and reply to user comments. The benefits of the Canna App to the cannabis community will be tremendous and fits in perfectly with Alliance Growers’ strategy as we will be able to distribute pharmaceutical grade CBD oil to the various dispensaries as we develop that data base.  The development of the Canna App augments our strategy of setting the Company up for success by taking it to where the cannabis industry will be in the future.”

About Alliance Growers Corp.

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 


February 14, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to provide an update on our projects that will ultimately make Alliance Growers a successful global cannabis company.   Our main strategy entails setting the Company up for success by taking it to where the cannabis industry will be in the future.

$5 Million to $10 Million Equity Facility with Private Equity Firm  

In addition to the current private placement, Alliance is currently negotiating terms on an equity facility to meet our capital requirements for the following projects.

Property Identified for Cannabis Botany Centre

BRIM and Alliance have identified a property upon which to build the 40,000 square foot Cannabis Botany Centre.  It consists of 40 acres of land in Miracle Valley, east of Mission, with the potential to develop up to 1 million square feet of facility space.  This property has zoning that is approved for Health Canada Licensed Producer facilities.  Thanks to the tremendous potential in the cannabis space, we now have multiple options to finance the purchase of the land and the construction of the facility.

Strategic alliances and investments in Licensed Producer Applicants

Through a serious of strategic alliances and investments in Licensed Producers at various stages in the license process, Alliance Growers is focused on securing long term plantlet supply contracts for the Cannabis Botany Centre and off-take agreements at wholesale cost for flower to be used for cannabidiol (CBD) oil extraction.

Later this week, Alliance Growers will announce the final terms on a 5% non-dilutive interest in a private company in Ontario that has assembled a top tier growing team with management that has the expertise to expedite the license producer application process.

Additional Licensed Producer Applicants have approached Alliance looking to partner with a public company and negotiations are ongoing.

Permits secured by Israeli Medical Cannabis Company

Further to the Company’s commitment to become a leading supplier of pharmaceutical grade CBD oil on a global basis, Alliance continues discussions setting out terms for an equity investment and/or joint venture with an Israeli medical cannabis company.

Last week the Company was informed that all permits were in place on 45-50 hectares of land for the growth of high quality cannabis plants in an offshore, low operating cost jurisdiction.  The Israeli medical cannabis company brings first-class technology for production and processing based on Israeli technology in addition to specific strains and processing knowhow.

This would facilitate the importation of the CBD oil into various states in the USA, into Canada when legalized, and into countries like Germany, now that the laws have changed.  We expect many more European countries to follow suit in the months to come.

The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD oils from marijuana-based sources are expected to reach $1,650,000,000, or 79% of the total CBD Market of $2,100,000,000 by 2020.  And this is in the USA only.

Dennis Petke, Alliance Growers’ President and CEO, stated “We are very excited to be able to take advantage of the equity facility to be able to execute on our business plan.  The equity firm we are negotiating with has financed other well-known Canadian cannabis companies in the past 2 years.  Over time we expect new investors and our shareholders to begin to see that we are building a truly global cannabis company, and this is what makes Alliance Growers stand out from other Canadian cannabis companies whose entire business is directly affected by Health Canada rules and regulations.”

About Alliance Growers Corp.

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 


February 10, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) is pleased to announce that the Company has commenced several initiatives for the German cannabis market.

Alliance Growers has begun activities to create awareness as a global cannabis company to investors in the German market.  Investor awareness activities will be undertaken throughout Germany translated into the German language.

The Company’s decision to commence activities at this time coincides with recent changes in drug laws.  Germany has created an amendment to the current drug laws specifically for severely ill individuals, such as AIDS and cancer patients, which allows patients access to medical cannabis.  The proposed draft bill put forward by the Health Ministry was adopted in the German parliament on January 19 and will take effect in March 2017. Cannabis treatments are typically very expensive, but the bill also allows for the costs of the medicine to be covered by health insurance companies.  This policy change is an important step forward toward a broader acceptance of medical cannabis as an effective treatment for patients in Germany.

To take advantage of these policy changes, Alliance is finalizing an agreement with Zeo Trade & Development Ltd., headquartered in Berlin, whereby Zeo Trade will be the Company’s German distribution partner.  In conjunction with this agreement Zeo Trade will undertake a study to determine the market potential and identify the best ways to take advantage of the opportunities in this new market, beginning with communications with the German Government Cannabis Agency.

Commenting on the German policy change, Dennis Petke, Alliance Growers’ President and CEO said, “We are very encouraged by the progressive policy changes that have been enacted in Germany. The country is providing the opportunity for seriously ill people to be cared for in the best way possible with support from the public health system by providing funding for cannabis prescriptions for patients. Given that the supply of medical cannabis products in Germany will be met primarily through imports from abroad, this fits perfectly with the Company’s business model to be a leading supplier of pharmaceutical grade CBD oil with a global reach.”

Commenting on the market activities and proposed partnership with Zeo Trade, Dennis Petke continued, “Over the past few months, Alliance Growers has been preparing several initiatives to create awareness among investors in the German market and we are now ready to ramp up our cannabis market activities and actively begin the Company’s planned investor relations outreach to the German investor”.

About Alliance Growers

Alliance Growers Corp. is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 

 

 

 


February 10, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA) (“Alliance Growers” or the “Company”) is pleased to announce that Edmund Obasi, owner of Obasi Investments has joined the Company’s Advisory Board.

 

Edmund Obasi has 14 year of relevant business experience, specializing in public companies business financing, private placements and medical marijuana related investments. Mr. Obasi is currently serving as the Chief Executive Officer, Chief Investment Officer and Director of OBASI INVESTMENT LIMITED, a private investment company registered in Alberta. Edmund completed his Master’s Degree in Applied Mathematics from the University of Waterloo Ontario. Mr Obasi’s diversified experiences to a wide range of business activities include oil and gas, mining, real estate, Cannabis and related products. Over the past several years, Mr. Obasi has been focusing extensively on research and investments in cannabis related public companies and the cannabis sector.

 

Mr. Obasi said, “The marijuana/cannabis sector is currently undergoing a revolutionary change towards legalization thereby resulting in significant market opportunities that can create enormous wealth for shareholders in the future. This provides a great opportunity for the development of viable industries that includes medicinal and recreational, social media, marijuana apps, marijuana infused products in beverages and candies, marijuana THC testing devices and many other opportunities. As a young industry, I am extremely excited about its potential and look forward to working with Dennis Petke, the Directors and other Officers at Alliance Growers in building tremendous future growth of ACG.

 

Commenting on Mr. Obasi joing the team, Dennis Petke, Alliance Growers President and CEO said, “I am pleased and honoured to be welcoming Edmund to The Alliance Growers team. He brings a bredth and depth of knowledge on the cannabis sector that will prove invaluable to our success as we enter a period of ramped up activities for the Company.”.

About Alliance Growers

Alliance Growers Corp (ACG: CSE; FWB: 1LA) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.


February 6, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA) (“Alliance Growers” or the “Company”) is pleased to announce that the Company has executed the founders agreement with a private Health Canada Licenced Producer Applicant based in Ontario that has assembled a top tier growing team with management that has the expertise to expedite the license producer application process.

 

Previously, on December 6, 2016, Alliance announced that it has entered negotiations to acquire a 10% non-dilutive interest in this private company.  After a series of negotiations, the parties have agreed on a 5% non-dilutive interest and are finalizing terms this week.

 

The next step is the execution of the final agreement with a $25,000 first payment for the equity investment.  The agreement will include long term plantlet supply contract and an offtake agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

Commenting on the strategic investment, Dennis Petke, Alliance Growers President and CEO said, “Through a serious of strategic alliances and investments in Licensed Producers at various stages in the license process we will further our business model of supplying plantlets to growers from our Cannabis Botany Centre, in addition to acquiring high quality flower for extraction.  By making strategic alliances in Eastern Canada we expect to identify partners for the joint development of multiple Botany Centres in Canada under our exclusive license of the B.R.I.M. technologies.   The development of these Botany Centres in Canada and in other countries will significantly add to the value of Alliance, along with interests we expect to acquire in multiple Health Canada Licensed facilities”.

About Alliance Growers

Alliance Growers Corp (ACG: CSE; FWB: 1LA) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.


February 3, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA) (“Alliance Growers” or the “Company”) is pleased to announce that after two months of searching it has identified the ideal property for its Cannabis Botany Centre.

Working with Peter Wojcik of B.R.I.M., three properties have been identified, but one in particular has been chosen by Alliance Growers to make an offer on. as it is the best fit for the Cannabis Botany Centre.  It consists of 40 acres of land in Miracle Valley, east of Mission with some of the best water quality in the Greater Fraser Valley.  This property has zoning that is approved for Health Canada Licenced Producer facilities.

Located in the Agricultural Belt, this property is ideal for the Cannabis Botany Centre, with the potential to develop 1 million square feet plus of useable land.  Mr. Wojcik has previously received approval from the municipality for MMPR use in this area on a different project.

Dennis Petke, Alliance Growers’ President and CEO commented “We are quite excited to have identified what we think is the ideal property for the Cannabis Botany Centre.  Having the capacity for over 1 million square feet of usable land makes for multiple development opportunities with cannabis under the various Health Canada Licenses we will be applying for.”

Commenting further “The opportunity for Alliance Growers to make strategic investments in LP’s provides two great benefits.  Firstly, pre-sales of plantlet supply contracts get the Cannabis Botany Centre to revenue immediately following our license approval from Health Canada to sell marijuana plantlets within Canada and for export to other countries where legal to do so. The second is off-take agreements of raw flower at wholesale for our own private CBD oil extraction requirements.”

Commenting on Alliance Growers’ strategy, Dennis Petke continues. “Our strategy goes beyond taking the Company to where the cannabis industry is today, but better yet, setting the Company up for tremendous success by taking Alliance Growers directly to where the cannabis industry will be in the future.”

Strategy Update

Alliance Growers is featured on Investing News Network

http://investingnews.com/company-profiles/alliance-growers-medical-cannabis-cbd-oil

Alliance Growers has secured a licensing agreement with Botanical Research in Motion (“B.R.I.M.”) which will allow for the joint development and operation of multiple Cannabis Botany Centres in North America. The agreement includes B.R.I.M.’s proprietary Chibafreen Invitro Plant Production System, which assures consistent composition and purity for each plantlet, and proprietary Cryotissue Cold Storage technology.

The first Cannabis Botany Centre is the staged development of a 40,000-square foot facility to be located near Vancouver, British Columbia. The facility will be the first of its kind in western Canada to include a DNA Botany lab, extraction facility and tissue culture plantlet production facility. The Botany Centre will have the ability to not only service the cannabis market, but other plant-based agricultural markets as well.

Alliance Grower’s Cannabis Botany Centre will offer customers

  • Disease free, genetically perfect plantlets to growers of all sizes
  • Botanical DNA services for certifying plant tissue at the genetic level
  • Cold storage technology for tissue culture preservation; and
  • Extraction services for CBD oils for retail markets.

Alliance is building strategic partnerships and distribution networks while securing long-term plantlet supply contracts and flower off-take agreements for CBD oil extractions. The Company is set to acquire a 5-percent non-dilutive interest in a private Ontario-based cannabis company led by a highly experienced team of growers.  This is the first of several strategic investments in licensed producers who are at various stages in the licensed producer application process. This agreement will include supplying plantlets to the private grower from Alliance’s Cannabis Botany Centre, in addition to acquiring high quality flower at wholesale cost for CBD oil extraction. This partnership is a step toward the development of future botany centres in eastern Canada under the company’s exclusive license of B.R.I.M. technologies.

Alliance continues its negotiations with an Israeli medical cannabis company to create a joint venture to develop pharmaceutical grade cannabidiol oil (CBD Oil) for global distribution.

Included in the discussions is the joint development of 45-50 hectares of land for the growth of high quality cannabis plants, as legally permitted in an offshore, low operating cost jurisdiction.  It is anticipated that the majority of the plant production would be processed for the extraction of pharmaceutical grade CBD Oil.  This would facilitate the importation of the CBD Oil into various states in the USA, into Canada when legalized, and into other countries as permitted.

The potential partner has a team of scientists, designers, and engineers committed to developing high quality medial cannabis. The Company’s R&D is based in Israel and involves both scientific and academic research as well as current ongoing registered medical clinical studies, of which Alliance gains the benefit of once we are joint venture partners.

About Alliance Growers

Alliance Growers Corp (ACG: CSE; FWB: 1LA) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution,  and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.